Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonya Cressman

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Science (New York, N.Y.)|February 8, 2003
Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis proteinGerd G Kochendoerfer, Shiah-Yun Chen, Feng Mao, et al.
The Lancet. Oncology|December 13, 2021
USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort studyMartin C Tammemägi, Mamta Ruparel, Alain Tremblay, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 14, 2017
The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program EfficiencySonya Cressman, Stuart J Peacock, Martin C Tammemägi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 9, 2014
Resource utilization and costs during the initial years of lung cancer screening with computed tomography in CanadaSonya Cressman, Stephen Lam, Martin C Tammemagi, et al.
The Lancet. Oncology|October 23, 2017
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective studyMartin C Tammemagi, Heidi Schmidt, Simon Martel, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Science (New York, N.Y.)|February 8, 2003
Design and chemical synthesis of a homogeneous polymer-modified erythropoiesis proteinGerd G Kochendoerfer, Shiah-Yun Chen, Feng Mao, et al.
The Lancet. Oncology|December 13, 2021
USPSTF2013 versus PLCOm2012 lung cancer screening eligibility criteria (International Lung Screening Trial): interim analysis of a prospective cohort studyMartin C Tammemägi, Mamta Ruparel, Alain Tremblay, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 14, 2017
The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program EfficiencySonya Cressman, Stuart J Peacock, Martin C Tammemägi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 9, 2014
Resource utilization and costs during the initial years of lung cancer screening with computed tomography in CanadaSonya Cressman, Stephen Lam, Martin C Tammemagi, et al.
The Lancet. Oncology|October 23, 2017
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective studyMartin C Tammemagi, Heidi Schmidt, Simon Martel, et al.
Pageof 4